Currently, the Government Pharmaceutical Organization (GPO) is planning to expand the production capacity of the live avian influenza vaccine (H5N2) (Fluvac H5) to cope with the outbreak. GPO has a plan to expand the production capacity to apply for a license at the industrial level and to develop vaccine production to be in line with current standards. It will produce 100,000-400,000 doses of vaccine per year to obtain data to support the application for industrial production formula registration within this year.
credit : สล็อตเว็บตรง